Please use this identifier to cite or link to this item:
Title: Serotypes and Clonal Composition of Streptococcus pneumoniae Isolates Causing IPD in Children and Adults in Catalonia before 2013 to 2015 and after 2017 to 2019 Systematic Introduction of PCV13
Author: Redin, A.
Ciruela, Pilar
Fernández de Sevilla Estrach, Mariona
Gómez Bertomeu, F.
González Peris, Sebastià
Benítez, Miguel A.
Trujillo, G.
Díaz Conradi, Álvaro
Jou, E.
Izquierdo, Conchita
Pérez Moreno, M.O.
Moraga Llop, Fernando A.
Olsina, M.
Vinado, B.
Sanfeliu, Esther
Garcia, A.
González Di Lauro, S.
García García, Juan José
Domínguez García, Àngela
Sá-Leao, Raquel
Muñoz-Almagro, Carmen
Catalan Study Group of Invasive Pneumococcal Dis
Keywords: Infeccions per pneumococs
Vacuna antipneumocòccica
Pneumococcal Infections
Pneumococcal vaccine
Issue Date: 1-Dec-2021
Publisher: American Society for Microbiology Press, Washington DC, USA,
Abstract: The goal of this study was to investigate the distribution of serotypes and clonal composition of Streptococcus pneumoniae isolates causing invasive pneumococcal disease (IPD) in Catalonia, before and after systematic introduction of PCV13. Pneumococcal strains isolated from normally sterile sites obtained from patients of all ages with IPD received between 2013 and 2019 from 25 health centers of Catalonia were included. Two study periods were defined: presystematic vaccination period (2013 and 2015) and systematic vaccination period (SVP) (2017 to 2019). A total of 2,303 isolates were analyzed. In the SVP, there was a significant decrease in the incidence of IPD cases in children 5 to 17 years old (relative risk [RR] 0.61; 95% confidence interval [CI] 0.38 to 0.99), while there was a significant increase in the incidence of IPD cases in 18- to 64-year-old adults (RR 1.33; 95% CI 1.16 to 1.52) and adults over 65 years old (RR 1.23; 95% CI 1.09 to 1.38). Serotype 8 was the major emerging serotype in all age groups except in 5- to 17-year-old children. In children younger than 5 years old, the main serotypes in SVP were 24F, 15A, and 3, while in adults older than 65 years they were serotypes 3, 8, and 12F. A significant decrease in the proportions of clonal complexes CC156, CC191, and ST306 and an increase in those of CC180, CC53, and CC404 were observed. A steady decrease in the incidence of IPD caused by PCV13 serotypes indicates the importance and impact of systematic vaccination. The increase of non-PCV13 serotypes highlights the need to expand serotype coverage in future vaccines and rethink vaccination programs for older adults. IMPORTANCE We found that with the incorporation of the PCV13 vaccine, the numbers of IPD cases caused by serotypes included in this vaccine decreased in all of the age groups. Still, there was an unforeseen increase of the serotypes not included in this vaccine causing IPD, especially in the >65-year-old group. Moreover, a significant increase of serotype 3 included in the vaccine has been observed; this event has been reported by other researchers. These facts call for the incorporation of more serotypes in future vaccines and a more thorough surveillance of the dynamics of this microorganism.
Note: Reproducció del document publicat a:
It is part of: Microbiology Spectrum, 2021, vol. 9, num. 3, p. e0115021
Related resource:
ISSN: 2165-0497
Appears in Collections:Articles publicats en revistes (Cirurgia i Especialitats Medicoquirúrgiques)

Files in This Item:
File Description SizeFormat 
718291.pdf1.79 MBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons